February 2013 - Page 6 of 14

WednesdayFeb 20, 2013 7:51 am

Vitesse Semiconductor Corp. (VTSS) VeriTime™ Announced as Finalist for 2013 China ACE Awards

Vitesse Semiconductor, a leading provider of advanced IC solutions for Carrier and Enterprise networks, announced that its VeriTime™ chipset was chosen as a finalist for the 2013 China Annual Creativity in Electronics (ACE) Awards in the Product of the Year, Mixed Signal Controller/Processor/SoC category. The nominated chipset is comprised of SynchroPHY™ 1 Gigabit Ethernet (GE), 10GE and 10GE OTN PHYs, and Carrier Ethernet Switch Engines, which makes use Vitesse’s IEEE1588v2 LTE-Advanced-ready VeriTime technology. Organized by Global Sources, the China ACE Awards honor the technologies, companies, and people that shape innovative electronics design in mainland China. Qualified by the ACE Award…

WednesdayFeb 20, 2013 7:50 am

VIASPACE, Inc. (VSPC) Signs Contract with $300 Million Company, Reports Energy Crop Growth in Nicaragua

Today before the opening bell, VIASPACE announced that it has entered into a contract with AGRICORP of Managua, Nicaragua, and is growing Giant King™ Grass on land owned by them. It is anticipated that AGRICORP shareholders and VIASPACE will co-develop a biomass electric power plant fueled by Giant King Grass in Nicaragua. A subsidiary of Grain Hill, AGRICORP has sales of $300 million per year with operations in Nicaragua, Costa Rica, and El Salvador. Grain Hill is a diversified agro-industrial business group and well known as the largest rice company in Nicaragua with 65% market share. AGRICORP/Grain Hill is engaged…

WednesdayFeb 20, 2013 7:50 am

ISC8, Inc. (ISCI) Launches Malware Research Team to Combat Malware Threats, Advance Cybersecurity Solutions

ISC8, a developer of intelligent cybersecurity, has established ISC8’s Malware Research Team (MRT) comprised of network security researchers, advisors, analysts, and engineers, each backed with inventive malware expertise that will be incorporated into the company’s Cyber adapt™ solution. Cyber adAPT function is to identify advanced threats in enterprise, service provider, and defense networks. In an age of rapidly advancing computer technology, advanced malware grows at an increasingly commensurate pace. ISC8’s MRT was implemented to work in collaboration with this solution to identify emerging threats. ISC8 says that while the MRT first and foremost was established to protect customers, the team…

WednesdayFeb 20, 2013 7:49 am

Viscount Systems, Inc. (VSYS) Acquires Contract to Secure Facility for International Manufacturer

Viscount Systems, a leading-edge supplier of security systems and software, this morning announced that it has received an initial order for its Freedom access control solution from an international manufacturer and supplier of industrial solutions. According to the press release, this contract could potentially lead to securing a total of 65 facilities owned or managed by this client. The systems to be installed will include Freedom access control running on Viscount’s patent-pending Microsoft Active Directory platform. Microsoft’s virtualization platform that makes it easier for businesses to virtualize existing server hardware assets and move them to the cloud. “This project demonstrates…

TuesdayFeb 19, 2013 2:27 pm

Viscount Systems, Inc. (VSYS) Thinks It’s Time for a Change

Viscount Systems designs, manufactures, and services a range of access control and security products for clients around the world. The company focuses on door access control, emergency communications, and other security systems and components currently installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices. They’ve been in the industry since 1969, but today they’re one of the few that have positioned themselves for major security changes that are long overdue. Access control, a $10 billion part of the $100 billion security market, has been dominated by multi-national corporations, such as Honeywell and UTC.…

TuesdayFeb 19, 2013 10:39 am

Savient Pharmaceuticals, Inc. (SVNT) and Sobi Announce Agreement to Co-Promote Kineret in the US

Savient Pharmaceuticals is a specialty biopharmaceutical company whose mission is to develop and commercialize pharmaceutical specialty products. The company announced today that it and Swedish Orphan Biovitrum AB (SOBI) have entered into an agreement for the co-promotion of Kineret (anakinra) in the United States. Sobi, an international specialty healthcare company dedicated to treatments for rare diseases, has a product portfolio primarily focused on inflammation and genetic diseases, with three late-stage biological development projects. Additionally, the company markets a portfolio of specialty and rare products with overseas partners such as Savient. Kineret, a recombinant IL-1 receptor antagonist, is a treatment for…

FridayFeb 15, 2013 2:36 pm

GlobalWise Investments, Inc. (GWIV) and the World Computer

Cloud technology, in its many and varied manifestations, is becoming as big a revolution for the Internet as the Internet itself has been for business and personal communication. Computers by themselves allow us to store and process tremendous amounts of information on a local basis. The Internet has allowed us to link the world’s computers, effectively replacing the information on our local computer with virtually unlimited information through the global computer network. Today, cloud technology is pursuing the next logical step, allowing us to capture and utilize not just information but processing functionality from all over the world. In effect,…

FridayFeb 15, 2013 2:35 pm

Northwest BioTherapeutics, Inc. (NWBO) Advances Toward Commencement of Phase III Brain Cancer Trial in Europe

Today, Northwest Biotherapeutics announced that it has named a leading international contract research organization (CRO) to manage its 312-patient Phase III clinical trial for Glioblastoma multiforme (GBM) brain cancer in Europe – building on almost three years of manufacturing development, regulatory processes, and clinical preparations there. Well underway in the United States, NW Bio’s Phase III trial is currently enrolling at 41 sites. The U.S. trial is being managed by a U.S. CRO that does not have operations in Europe that can accommodate this trial. Having undergone considerable preparations and regulatory approvals in Europe, the trial is poised to begin…

FridayFeb 15, 2013 2:34 pm

Rafarma Pharmaceuticals, Inc. (RAFA) is “One to Watch”

Rafarma Pharmaceuticals, Inc. is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia. Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by…

FridayFeb 15, 2013 10:54 am

Liberator Medical Holdings, Inc. (LBMH) Reports First Quarter Revenue of $17.6 Million

The subsidiary of Liberator Medical Holdings, Liberator Medical Supply, established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible senior citizens. The company offers a simple, reliable way to buy medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance companies. The company yesterday announced the financial results for its first fiscal quarter ended December 31, 2012. Sales increased by $2.755 million, or 18.6%, to $17.551 million, versus sales of $14.796 million in the same year ago period. The increased sales were due to…

Site Search

Company Search

Month: February 2013